📰 Trepl News
Page 3 - Trepl News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Trepl. Real-time updates on events, politics, business and more.
October 1, 2023
Replimune Group, Inc. (NASDAQ:REPL – Get Free Report) shares traded down 3.2% during trading on Friday . The stock traded as low as $15.93 and last traded at $15.98. 125,998 shares traded hands during mid-day trading, a decline of 78% from the average session volume of 563,938 shares. The stock had previously closed at $16.50. […]
September 22, 2023
Replimune Group, Inc. (NASDAQ:REPL – Get Free Report) was down 4.2% during trading on Wednesday . The company traded as low as $17.01 and last traded at $17.08. Approximately 315,762 shares changed hands during mid-day trading, a decline of 44% from the average daily volume of 563,851 shares. The stock had previously closed at $17.83. […]
September 7, 2023
Panagora Asset Management Inc. raised its holdings in shares of Replimune Group, Inc. (NASDAQ:REPL – Free Report) by 0.8% during the first quarter, according to its most recent filing with the SEC. The firm owned 67,890 shares of the company’s stock after purchasing an additional 568 shares during the period. Panagora Asset Management Inc. owned […]
August 18, 2023
Replimune Group, Inc. (NASDAQ:REPL – Get Free Report) insider Pamela Esposito sold 1,400 shares of Replimune Group stock in a transaction dated Friday, August 11th. The stock was sold at an average price of $20.00, for a total value of $28,000.00. Following the sale, the insider now directly owns 263,436 shares of the company’s stock, […]
August 12, 2023
Integral Health Asset Management LLC increased its holdings in shares of Replimune Group, Inc. (NASDAQ:REPL – Free Report) by 79.5% during the 1st quarter, Holdings Channel.com reports. The fund owned 395,000 shares of the company’s stock after acquiring an additional 175,000 shares during the period. Integral Health Asset Management LLC’s holdings in Replimune Group were […]
August 12, 2023
Integral Health Asset Management LLC lifted its stake in shares of Replimune Group, Inc. (NASDAQ:REPL – Free Report) by 79.5% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 395,000 shares of the company’s stock after acquiring an additional 175,000 shares during the […]
August 9, 2023
Replimune Group (NASDAQ:REPL – Free Report) had its price target reduced by HC Wainwright from $51.00 to $50.00 in a report published on Monday, MarketBeat.com reports. They currently have a buy rating on the stock. Separately, Piper Sandler reiterated an overweight rating and issued a $44.00 target price on shares of Replimune Group in a […]
August 5, 2023
HC Wainwright reiterated their buy rating on shares of Replimune Group (NASDAQ:REPL – Free Report) in a report released on Tuesday morning, Benzinga reports. The brokerage currently has a $51.00 target price on the stock. Separately, Piper Sandler reiterated an overweight rating and issued a $44.00 target price on shares of Replimune Group in a […]
August 4, 2023
Replimune Group (NASDAQ:REPL – Get Free Report) issued its quarterly earnings results on Thursday. The company reported ($0.75) EPS for the quarter, topping analysts’ consensus estimates of ($0.80) by $0.05, Briefing.com reports. During the same period in the prior year, the firm earned ($0.78) earnings per share. Replimune Group Stock Up 2.8 % REPL stock […]
August 4, 2023
Replimune Group (NASDAQ:REPL – Get Free Report) issued its quarterly earnings data on Thursday. The company reported ($0.75) EPS for the quarter, beating analysts’ consensus estimates of ($0.80) by $0.05, Briefing.com reports. During the same period last year, the business earned ($0.78) earnings per share. Replimune Group Price Performance NASDAQ REPL traded up $0.54 during […]